For instance, Fossaluza et al. assessed the clinical differences of patients with primary Sjögren’s syndrome based on either ANA and/or anti-ENA antibody-negative or -positive cases, therefore excluding the non-identified ANA-positive subgroup [11]. This evidence concerns the gene ENAH and Sjogren syndrome.